Kennametal: FY20 Restructuring Actions On Track - Quick Facts

Kennametal Inc. (KMT) said the company has made good progress on its restructuring actions for fiscal 2020. The company recently completed the full closures of its manufacturing facilities in Lichtenau, Germany and Irwin, Pennsylvania. The actions will begin to reduce structural costs beginning in the second half of fiscal 2020. The restructuring actions are expected to result in annualized savings of $35 to $40 million with pre-tax-charges of $55 to $65 million.

Under fiscal 2021 restructuring actions, Kennametal plans to deliver original estimated annualized savings of $25 to $30 million but with lower estimated pre-tax charges of approximately $55 to $65 million, down from $60 to $75 million.

The company has agreed to downsize the Essen, Germany facility instead of the previously proposed closure. The agreement between Kennametal and the Essen employee representatives is effective through June 30, 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The five-day holiday shopping period from Thanksgiving Day through Cyber Monday saw about 180 million Americans making in-store and online purchases, according to the National Retail Federation's Annual Thanksgiving Weekend Consumer Survey, conducted by Prosper Insights & Analytics. The shoppers spent an average of $301.27 on holiday-related purchases such as gifts, décor, apparel and toys. Biopharmaceutical company Immunome, Inc. (IMNM) announced Wednesday that it has conducted an assessment of the reported mutations in the new SARS-CoV-2 variant, Omicron (B.1.1.529). Based upon structural mapping of those mutations and activity against previous and current CDC variants of concern,... CVS Health said it has installed time delay safe technology in all 392 Illinois CVS Pharmacy locations, including those in Target stores, to help reduce organized retail crime. The installation of new safes for controlled substances are anticipated to help prevent pharmacy robberies. There is also potential for associated diversion of controlled substance medications, including opioid medications.
Follow RTT